Related Experiment Videos

Achieving equity in the Australian healthcare system

Robert N Atkinson

The Medical Journal of Australia

|March 12, 2004

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic pain.

Bioorganic & medicinal chemistry·2010

Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivatives.

Bioorganic & medicinal chemistry letters·2010

A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.

Neuropharmacology·2010

Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.

Bioorganic & medicinal chemistry·2008

Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.

Journal of medicinal chemistry·2008

Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidine.

Journal of medicinal chemistry·2007

See all related articles